Hemato-immunology & Stem Cell Research
Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.
- Blood Groups and Rh Incompatibility
- B and T-Lymphocyte
- Hematology and Clinical Immunology
- Immunology of Blood Cancer
- Inflammatory/Autoimmune Diseases
- Bone Marrow Stem Cell Therapy
- Stem Cell Transplantation Strategies
Related Conference of Hemato-immunology & Stem Cell Research
Hemato-immunology & Stem Cell Research Conference Speakers
Recommended Sessions
- Blood Disorders and Blood Oncology
- Blood Transplantation, Thrombosis and Hemostasis
- Blood- Components and Functions
- Diagnosis, Treatment and Management of Blood Disorders
- Effect of Advanced Technologies on Blood Based Products
- Hemato-immunology & Stem Cell Research
- Hematologic Malignancies
- Lymph and Associated Diseases
- New Drug Development in Haematology
- Transfusion Medicine and Haematology Research
- Tropical Blood Disorders
- Various Aspects of Haematology
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Biomarkers in Hematology and Oncology - Hematology Congress 2025 (Switzerland)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2025 (Switzerland)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Cancer Genomics & Metabolomics - Hematology Congress 2025 (Switzerland)
- Case Reports in Hematology - Hematology Congress 2025 (Switzerland)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- Clinical Haematology - Hematology Congress 2025 (Switzerland)
- Cord Blood Transplantation - Hematology Congress 2025 (Switzerland)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Digital Imaging in Hematology - Hematology Congress 2025 (Switzerland)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Haematology and Pharma Industry - Hematology Congress 2025 (Switzerland)
- Hematologic Cancers - Hematology Congress 2025 (Switzerland)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology and Cardio-Oncology - Hematology Congress 2025 (Switzerland)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Nursing - Hematology Congress 2025 (Switzerland)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Hematology: Diagnostics and Screening - Hematology Congress 2025 (Switzerland)
- Hematopoietic Malignancies - Hematology Congress 2025 (Switzerland)
- Immunohematology - Hematology Congress 2025 (Switzerland)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- Neuro-Hematology - Hematology Congress 2025 (Switzerland)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Organ Specific Cancer - Hematology Congress 2025 (Switzerland)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Therapy - Hematology Congress 2025 (Switzerland)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Medicines - Hematology Congress 2025 (Switzerland)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)
- Vascular Bleeding Disorders - Hematology Congress 2025 (Switzerland)